Abbott shares fell after quarterly sales and early 2026 earnings guidance missed estimates, even as the company forecast ...

What Happened? Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 8.3% in the afternoon ...

Abbott Laboratories reported Q4 2025 sales of $11.46 billion, an increase of 4.4% from the previous year but falling short of analyst projections by approximately 3%. The adjusted EPS was $1.50, ...

Abbott shares sank 8% as Q4 revenue of $11.5B missed the $11.8B target, with nutrition sales dropping 8.9% on price ...

Abbott stock fell more than 7% in premarket trading after the company missed on Q4 revenue and gave a weaker Q1 2026 outlook, ...

Abbott (ABT) delivered earnings and revenue surprises of +0.20% and -2.76%, respectively, for the quarter ended December 2025 ...

Stock futures inched higher Thursday as easing geopolitical fears drove a broad market rally, with traders digesting a softer ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you ...

We recently compiled a list of the 10 Best Investments During A Recession. The seventh stock on our list of best investments ...

Abbott (NYSE: ABT) recently reported its Q4 results, with revenues marginally below and earnings meeting the street expectations. The company reported revenue of $10.97 billion and earnings of $1.34 ...